on May 25, 2026
Inflammation is an essential physiological process for survival: it represents the body's adaptive response to harmful stimuli, aimed at healing. However, when this mechanism becomes chronic and loses its regulated function, it transforms into a subtle and systemic condition known as silent chronic inflammation or low-grade inflammation.
This condition, often lacking obvious symptoms, is today considered one of the main pathogenic factors underlying numerous chronic degenerative diseases.
What is silent chronic inflammation
Unlike acute inflammation — characterized by obvious clinical signs (rubor, calor, tumor, dolor, functio lesa) — silent chronic inflammation is a persistent, low-intensity state that can last for years without significant clinical manifestations.
Over time, this state leads to:
- increased pro-inflammatory cytokines (TNF-α, IL-6, IL-1β)
- chronic immune system activation
- progressive tissue damage
- metabolic and degenerative alterations
It is closely related to the phenomenon of inflammaging, namely aging associated with a chronic inflammatory state.
Main causes
Silent chronic inflammation is multifactorial and stems from a combination of factors:
- pro-inflammatory diet (refined sugars, trans fats)
- sedentary lifestyle
- chronic stress
- environmental pollution
- intestinal dysbiosis
- sleep disorders
At the cellular level, it is associated with:
- oxidative stress
- advanced glycation end products (AGEs)
- tissue acidosis
These mechanisms feed into each other in a vicious cycle that accelerates the deterioration of the body.
Health consequences
Numerous studies have demonstrated the association between chronic inflammation and the development of:
- cardiovascular diseases
- type 2 diabetes and metabolic syndrome
- neurodegenerative diseases (e.g., Alzheimer's, Parkinson's)
- cancers
- autoimmune diseases
Chronic inflammation therefore represents a true pathological predisposing ground.
Therapeutic approach: why pharmacology alone is not enough
The traditional pharmacological approach is not always applicable, especially in asymptomatic subjects, due to the risk of side effects.
For this reason, the modern approach is based on:
- lifestyle modification
- anti-inflammatory nutrition
- targeted nutraceutical supplementation
The goal is not to block a single pathway, but to modulate the entire inflammatory network.
Natural substances with anti-inflammatory action
Turmeric (Curcuma longa)
Curcumin is one of the most studied natural compounds in the anti-inflammatory field.
Main mechanisms:
- inhibition of NF-κB
- reduction of TNF-α and interleukins
- modulation of COX-2 and LOX
Clinical evidence:
- efficacy in osteoarthritis comparable to NSAIDs with better tolerability (Panahi et al., 2016; Daily et al., 2016)
- reduction of CRP and inflammatory markers (Sahebkar et al., 2016)
- benefits in ulcerative colitis (Simadibrata et al., 2017)
Tetrahydrocurcumin (THC)
Curcumin metabolite with:
- greater stability
- better bioavailability
- high antioxidant activity
Particularly useful in contexts of systemic oxidative stress.
Bromelain (Ananas comosus)
Enzyme complex with:
- anti-inflammatory
- anti-edematogenic
- fibrinolytic
Clinical evidence:
- reduction of postoperative edema and pain (de Souza et al., 2019)
- improvement in rhinosinusitis (Wu et al., 2020)
- efficacy in musculoskeletal pain (Walker et al., 2002)
Mechanism:
- cytokine modulation
- action on prostaglandins
- immune response regulation
Boswellia serrata
Source of boswellic acids (AKBA), potent 5-lipoxygenase inhibitors.
Mechanisms:
- leukotriene reduction
- NF-κB inhibition
- cartilage protection
Clinical evidence:
- improvement in pain and function in osteoarthritis (Kimmatkar et al., 2003; Sengupta et al., 2010)
- efficacy in inflammatory bowel diseases (Gupta et al., 1997)
Nutraceutical synergy: an integrated approach
The combined use of:
- bromelain
- boswellia
- tetrahydrocurcuminoids
allows action on multiple levels of the inflammatory cascade:
- lipid mediators (prostaglandins, leukotrienes)
- cytokines
- oxidative stress
- tissue edema
This multi-target approach is consistent with the complexity of chronic inflammation.
Safety and clinical considerations
Natural substances generally have a good safety profile, but it is important to consider:
- drug interactions (anticoagulants, chemotherapy)
- hepatobiliary conditions (turmeric)
- allergies (bromelain)
Regulatory authorities such as EFSA and EMA recognize the safety of turmeric within defined limits (ADI: 3 mg/kg/day).
Silent chronic inflammation is one of the main drivers of modern diseases. Its management requires an integrated approach that includes:
- a healthy lifestyle
- functional nutrition
- targeted nutraceutical support
Scientific evidence supports the use of natural compounds such as curcumin, bromelain, and boswellia as effective tools in modulating inflammatory processes, with a good safety profile.
